While tremendous improvement has been made for the treatment of breast cancers, the
treatment of triple negative breast cancer (TNBC) still remains a challenge due to its …

Breast cancer is a highly prevalent disease, accounting for 29% of invasive cancers in
women. Survival from this disease depends on the stage at diagnosis, with patients who are …

MicroRNAs are dysregulated in breast cancer. Heterogeneous Nuclear Ribonucleoprotein
A2/B1 (HNRNPA2/B1) is a reader of the N (6)-methyladenosine (m6A) mark in primary …

MicroRNAs are small noncoding RNAs which regulate gene expressions at post-
transcriptional level by binding to the 3′-untranslated region of target messenger RNAs …

Pregnancy-associated breast cancer (PABC) is commonly defined as a breast cancer
occurring during pregnancy, throughout 1 year postpartum, or during lactation. Despite …

Aberrant expression of certain microRNAs (miRNAs) has been implicated in cancers as a
promising druggable target due to the fact that a modulation of the deregulated single …

Breast cancer has become one of the most common dreadful diseases that target women
across the globe. The most obvious reasons we associate with it are either genetic …

Objectives: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer
with limited treatment options and poor prognosis. TNBC is usually diagnosed at a relatively …

Introduction Breast cancer metastasis is the main cause of cancer-related death in women
worldwide. Current therapies have remarkably improved the prognosis of breast cancer …

Background Pancreatic cancer is an aggressive cancer with dismal prognosis, urgently
necessitating better biomarkers to improve therapeutic options and early diagnosis …